AstraZeneca Announces Partnership with Singapore Institutions to Develop Anti-Cancer Compounds 19 August 2008 The collaboration aims to further build AstraZeneca's drug development capabilities in Asia and speed up access to new medicines of potential benefit to patients.
University of Texas Medical Branch and GenoLogics to Develop a Biomedical Informatics Solution 19 August 2008 The Sealy Center for Molecular Medicine at the UTMB has selected GenoLogics to collaborate on developing an integrated biomedical software solution.
Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 19 August 2008 Study to report findings on how genes impact efficacy of many commonly used prescription medications.
M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics' MicroRNA-based Diagnostic Assay 18 August 2008 The study will correlate the results of Rosetta Genomics' microRNA-based CUP assay with diagnostic work conducted at M.D. Anderson Cancer Center.
U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN® 14 August 2008 The trial is being carried out by the Mayo Phase 2 Consortium using systemic administration of Oncolytics' formulation of the human reovirus.
Tiny Molecule Helps Control Blood-Vessel Development, Researchers Find 14 August 2008 Findings show that the development and repair of heart tissue and blood vessels is intimately tied to a tiny piece of RNA that is found nowhere else in the body.
Molecular Switch Boosts Brain Activity Associated with Schizophrenia 14 August 2008 Researchers have identified in mouse brain tissue a molecular switch that, when thrown, increases the strength of brain electrical activity.
MabVax Therapeutics Closes Two Licensing Agreements with Sloan-Kettering Institute for Cancer Research 14 August 2008 MabVax gains exclusive development and commercialization rights to multiple vaccines and to use the licensed vaccines and lymphocytes from vaccinated trial participants.